Group One Trading’s Olema Pharmaceuticals OLMA Stock Holding History

Group One Trading’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$285K	Sell	22,746 -14,434	-39%	-$193K	﹤0.01%	3994
2026 Q1	$554K	Buy	+37,180	New	+$828K	﹤0.01%	3246
2025 Q3	–	Sell	-14,699	Closed	-$88.3K	–	8922
2025 Q2	$62.6K	Buy	14,699 +2,500	+20%	+$11.1K	﹤0.01%	5386
2025 Q1	$45.9K	Buy	+12,199	New	+$61.4K	﹤0.01%	5238
2024 Q1	–	Sell	-35,989	Closed	-$464K	–	7714
2023 Q4	$505K	Buy	+35,989	New	+$484K	﹤0.01%	3061
2022 Q3	–	Sell	-1,006	Closed	-$4.27K	–	8030
2022 Q2	$4K	Hold	1,006	–	–	﹤0.01%	7209
2022 Q1	$4K	Hold	1,006	–	–	﹤0.01%	7553
2021 Q4	$9K	Buy	+1,006	New	+$20.8K	﹤0.01%	7407

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Group One Trading's OLMA Position: Q2 2026 in Review

Group One Trading reduced its Olema Pharmaceuticals (OLMA) stake by 39% in Q2 2026, selling an estimated $193K and leaving 22,746 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #3994.

Group One Trading first reported a position in OLMA in Q4 2021 and has held it in 8 quarters since. The position peaked at $554K in Q1 2026. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

Group One Trading held 22,746 shares of Olema Pharmaceuticals worth $285K as of Q2 2026.
Group One Trading sold 14,434 Olema Pharmaceuticals shares in Q2 2026, an estimated $193K.
Olema Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3994 holding.
Group One Trading first reported a position in Olema Pharmaceuticals in Q4 2021 and has held it in 8 quarters since.
Group One Trading's Olema Pharmaceuticals position peaked at $554K in Q1 2026.
185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.